Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Biosimilar interchangeability: Do you know your switching from your substitution?

21 March 2017

US FDA interchangeability guidance adds another level of confusion over […]

Some EU countries effectively delay market entry of generics

17 March 2017

The harmonisation of different regulatory environments in the EU member […]

Biosimilar medicines: Increasing access to modern essential medicines while supporting sustainability of healthcare systems

16 February 2017

Biologic medicines have revolutionised the management of many serious diseases […]

Biosimilar medicines. Essential for increasing access to important medicines and the sustainability of healthcare systems

25 January 2017

Biologic medicines have revolutionised the management of many serious diseases […]

The global scourge of counterfeit medicines

8 November 2016

The statistics are truly disturbing, with an annual death toll […]

EU countries urged to promote generics, biosimilars to meet rising costs of long-term care – report

18 October 2016

LONDON, Oct 18 (APM) – European countries should promote greater […]

The global scourge of counterfeit medicines

29 September 2016

Generic Medicines Increase Access to Treatments

27 September 2016

Pharma expert: new ‘value added medicines’ offer cheaper, customised treatment

26 July 2016